The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030” report features an extensive study

Key Inclusions
The USD 1.5 billion (by 2030) financial opportunity within the cell and advanced therapies supply chain management market has been analysed across the following segments:
Application area
Sample collection and processing
Manufacturing
Logistics
Patient identification and treatment follow-up
Type of software solution
Cell orchestration platform
Enterprise manufacturing system
Inventory management system
Laboratory information management system
Logistics management system
Patient management system
Quality management system
Mode of Deployment
Cloud-based solution
On-premises solution
Scale of Operation
Clinical
Commercial
End user
Biobank
Cell therapy lab / commercial organization
Hospital / medical center
Research institute
Key geographical regions
North America
Europe
Asia Pacific
Rest of the world
To request a sample pages, please visit this link         
Key Questions Answered
  • What are the trending software solutions for the management of cell and advanced therapies supply chain?
  • Who are the leading industry and non-industry players in this domain?
  • What are the key challenges faced by various stakeholders in this domain?
  • What kind of partnership models are commonly adopted by stakeholders in this industry?
  • Who are the key investors in this field?
  • What is the current and likely future cost saving opportunities associated with supply chain management solutions?
  • How is the current and future market opportunity likely to be distributed across key market segments and geographies?
  • What factors are likely to influence the evolution of this upcoming market?
You may also be interested in the following titles:
Contact:
Gaurav Chaudhary

+1 (415) 800 3415

[email protected]



You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
628 Posts

Made with by Mamby